Adicet Bio, Inc. (ACET)

Adicet Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.13	38.92	56.5	159.71	257.66	277.54
Short-Term Investments	85.06	119.61	119.81	-	-	-
Cash & Short-Term Investments	118.19	158.53	176.3	159.71	257.66	277.54
Cash Growth	-5.42%	-10.08%	10.39%	-38.01%	-7.17%	193.34%
Accounts Receivable	-	-	-	-	-	0.19
Other Receivables	0.44	0.34	0.1	-	0.44	0.03
Receivables	0.44	0.34	0.1	-	0.44	0.21
Prepaid Expenses	2.13	2.05	3.74	2.56	2.95	4.68
Total Current Assets	120.76	160.93	180.14	162.27	261.04	282.44
Property, Plant & Equipment	24.45	28.48	36.75	44.2	48.98	35
Goodwill	-	-	-	-	19.46	19.46
Other Long-Term Assets	2.95	2.95	3.33	0.82	1.21	2.04
Total Assets	148.17	192.36	220.22	207.3	330.69	338.94

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.59	4.74	4.83	2.63	4.4	3.26
Accrued Expenses	11.58	13.61	11.43	13.44	12.81	6.68
Current Portion of Leases	2.83	3.19	3.13	3.22	2.49	1.57
Current Unearned Revenue	-	-	-	-	-	4.81
Total Current Liabilities	18	21.53	19.39	19.29	19.71	16.32
Long-Term Leases	10.03	11.55	14.1	17.7	18.53	19.38
Other Long-Term Liabilities	-	0.06	0.12	0.13	0.11	0.12
Total Liabilities	28.03	33.15	33.61	37.12	38.35	35.81

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0.01	0.01	0	0	0
Additional Paid-In Capital	776.54	773.8	684.48	550.94	530.45	471.45
Retained Earnings	-656.3	-614.7	-497.89	-380.77	-238.11	-168.32
Comprehensive Income & Other	-0.11	0.1	0.02	-	-	-
Total Common Equity	120.14	159.21	186.61	170.18	292.34	303.13
Shareholders' Equity	120.14	159.21	186.61	170.18	292.34	303.13
Total Liabilities & Equity	148.17	192.36	220.22	207.3	330.69	338.94

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.85	14.74	17.23	20.92	21.02	20.94
Net Cash (Debt)	105.34	143.79	159.07	138.79	236.63	256.6
Net Cash Growth	-3.90%	-9.60%	14.61%	-41.35%	-7.78%	251.63%
Net Cash Per Share	11.20	20.87	28.97	51.59	92.16	132.64
Filing Date Shares Outstanding	10.76	10.75	5.7	5.66	2.68	2.49
Total Common Shares Outstanding	10.76	10.74	5.69	2.7	2.68	2.48
Working Capital	102.76	139.4	160.74	142.99	241.33	266.12
Book Value Per Share	11.16	14.82	32.81	62.93	108.89	122.05
Tangible Book Value	120.14	159.21	186.61	170.18	272.88	283.67
Tangible Book Value Per Share	11.16	14.82	32.81	62.93	101.64	114.22
Machinery	14.89	14.85	15	14.31	7.86	6.02
Construction In Progress	0.01	0.2	0.2	0.27	9.29	13.01
Leasehold Improvements	28.6	28.42	28.23	26.64	19.96	1.61

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error